Back
Cardiff Oncology Stock Price Chart

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now
Buy
51
CRDF
Cardiff Oncology
Last Price:
$3.63
Seasonality Move:
19.16%
7 Day Trial
ALL ACCESS PASS
$
7

Your Summer Trading Shortcut
Try it free today.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRDF is experiencing slight selling pressure.
Cardiff Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.25 | Buy |
20-day SMA: | 3.52 | Buy |
50-day SMA: | 3.15 | Buy |
200-day SMA: | 3.31 | Buy |
8-day EMA: | 3.36 | Buy |
20-day EMA: | 3.36 | Buy |
50-day EMA: | 3.08 | Buy |
200-day EMA: | 1.62 | Buy |
Cardiff Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 57.15 | Buy |
Chaikin Money Flow: | -222906 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.16 - 3.82) | Buy |
Bollinger Bands (100): | (2.79 - 4.05) | Buy |
Cardiff Oncology Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cardiff Oncology Stock
Is Cardiff Oncology Stock a Buy?
-
Cardiff Oncology share price is 3.59 while CRDF 8-day simple moving average is 3.25, which is a Buy signal.
-
The stock price of CRDF is 3.59 while Cardiff Oncology 20-day SMA is 3.52, which makes it a Buy.
-
Cardiff Oncology 50-day simple moving average is 3.15 while CRDF share price is 3.59, making it a Buy technically.
-
CRDF stock price is 3.59 and Cardiff Oncology 200-day simple moving average is 3.31, creating a Buy signal.
CRDF Technical Analysis vs Fundamental Analysis
Buy
51
Cardiff Oncology (CRDF)
is a Buy
Is Cardiff Oncology a Buy or a Sell?
-
Cardiff Oncology stock is rated a BuyThe current Cardiff Oncology [CRDF] share price is $3.59. The Score for CRDF is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Cardiff Oncology Stock Info
Market Cap:
238.8M
Price in USD:
3.59
Share Volume:
1.4M
Cardiff Oncology 52-Week Range
52-Week High:
5.64
52-Week Low:
2.01
Buy
51
Cardiff Oncology (CRDF)
is a Buy
Cardiff Oncology Share Price Forecast
-
What is the Cardiff Oncology stock price today?The Cardiff Oncology stock price is 3.59 USD today.
-
Will CRDF stock go up or go down?Cardiff Oncology> share price is forecast to RISE/FALL based on technical indicators
-
Is Cardiff Oncology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cardiff Oncology is not overvalued.
Is Cardiff Oncology Stock a Buy?
-
Cardiff Oncology share price is 3.59 while CRDF 8-day exponential moving average is 3.36, which is a Buy signal.
-
The stock price of CRDF is 3.59 while Cardiff Oncology 20-day EMA is 3.36, which makes it a Buy.
-
Cardiff Oncology 50-day exponential moving average is 3.08 while CRDF share price is 3.59, making it a Buy technically.
-
CRDF stock price is 3.59 and Cardiff Oncology 200-day simple moving average is 1.62, creating a Buy signal.
Fundamental Analysis of Cardiff Oncology
Is Cardiff Oncology a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.15 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Cardiff Oncology
Should I short Cardiff Oncology stock?
-
CRDF Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Cardiff Oncology is a Buy
-
Cardiff Oncology Relative Strength Index (RSI) is 57.15, which suggest Cardiff Oncology is overbought
-
The Bollinger Bands (25) for Cardiff Oncology is (3.16 - 3.82), which suggest Cardiff Oncology is a Buy
-
The Bollinger Bands (100) for Cardiff Oncology is (2.79 - 4.05), which suggest Cardiff Oncology is a Buy
* Cardiff Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.